Puma Biotech (PBYI) Tops Q3 EPS by 59c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 11.34 +0.08 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.26 | 52 Week High | $82.81 | |||
| Open | $11.25 | 52 Week Low | $19.74 | |||
| Day High | $11.50 | P/E | N/A | |||
| Day Low | $11.05 | EPS | $-2.16 | |||
| Volume | 195,823 | |||||
